With the fourth revolution heralding large-scale digital connectivity across artificial intelligence learning systems and networks, the ability to connect digitally and transfer data across complex networks is fundamentally important to the pharmaceutical industry....
The Danish Medicines Agency (DKMA) is working to define criteria for the application of artificial intelligence (AI) and machine learning (ML) across GxP-regulated areas.  To understand the biopharmaceutical industry’s position, it has been gathering information using...
